Metzemaekers et al. (15) reported significantly higher levels of plasmatic tissue inhibitor of metalloproteinase 1 (TIMP-1) and of TIMP-1/MMP-9 complexes and significantly lower circulating total MMP activity in COVID-19 patients at intensive care unit (ICU) admission. The gene discussed is TIMP1; the disease is COVID-19.